Effects of B-cell directed therapy on the preclinical stage of rheumatoid arthritis: the PRAIRI study
Daniëlle M. Gerlag(UCB Pharma (United Kingdom)), Paul P. Tak(Celldex Therapeutics (United States)), Sander W. Tas(Amsterdam University Medical Centers), Astrid van Tubergen(Maastricht University), M. Safy(University of Amsterdam), Mirian Starmans‐Kool(Zuyderland Medisch Centrum), Aeilko H. Zwinderman(Amsterdam Neuroscience), Man Tang(University of Amsterdam), Monika Hansson(Karolinska Institutet), M. De Hair(University of Amsterdam), Karen I. Maijer(Amsterdam UMC Location University of Amsterdam), M. Janssen(Erasmus MC), Niek de Vries(Amsterdam UMC Location University of Amsterdam)
Cited by 289
Related Papers
NF-κB: a key role in inflammatory diseases
|Journal of Clinical Investigation|2001|3.9k
Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews
|Journal of Clinical Epidemiology|2005|3.3k
Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
|Pharmacology & Therapeutics|2007|1.6k
Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci
|Nature Genetics|2010|1.3k
Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia
|New England Journal of Medicine|2008|1.2k